- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01960868
Early Rehabilitation Program is Feasible and Safe in ICU in Liver Transplanted Patients
Liver transplantation is the last surgical treatment for patients with acute or chronic liver disease. Transplantation therapies technics are in constant evolution. It allows an increasing survivals rates and time to come back to daily activities. The postoperative treatment after abdominal surgery as Liver Transplantation (LT) is usually performed in Intensive Care Unit (ICU).This postoperative phase is one of the most important steps regarding the involvement of the rehabilitation of the patient (Rongies 2005). Physical abilities transplantation are likely to be important in the postoperative. It appears that pre-transplant subjects have a weakened muscle potential, they will increase it significantly in the months after transplantation with a rehabilitation program adapted (Beyer 1999). Length of stay in ICU depends on surgery complications. Inactivity induced by sedation and ICU length of stay are major factor for increasing complications as respiratory disorders and muscle weakness. Several studies have reported feasibility and safety an early mobility program in ICU, especially regarding the length of stay decrease (Bailey 2007; Morris 2008; Schweickret 2009, Needham 2010; Bourdin 2010) These early mobility programs encompass muscle strength assessment, passive range of motion, active mobility, sitting on the edge of bed, standing and walking, which would be related to the primary disease of LT (Rongies 2008). The assessment of the strength for ICU patient is feasible and reproducible with the Medical Research Council score (MRC score). The MRC score consists in an assessment of three muscle groups of upper and lower limbs. Sitting positions and verticalization are included in programs begun as soon as possible after surgery evaluation of the response level to verbal stimulation and physical abilities (Gosselink 2011). The skills of the physiotherapist are established in legal texts making him a key in the assessment and management of these patients on musculoskeletal and respiratory domains.
The purpose of this study is to validate data feasibility and tolerance. Another aim is also to assess the length of stay in ICU, of early mobility and physical program, started in the postoperative period in a population of patients with liver transplantation, during their stay in ICU of Prof. Albanese. Thus, we decided to carry out a parallel study, open, randomized monocentric comparing two groups of patient liver transplanted. The control group will receive the standard treatment used in the ICU and the experimental group will receive a protocol of early mobilization according to data from recent literature on the subject. The study is scheduled to last over one year and included patients will receive physical therapy on five days a week with a frequency of one to several times per day depending on the clinical requirements or conditions of the study.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hopitaux de Marseille
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patient more than 18 years,
- patient for a liver transplant
- patient that informed consent was obtained
Exclusion Criteria:
- patient whose consent has not been obtained,
- patient with major cons-indications to the application program (paralysis neuromyopathy majeure),
- patient with hemodynamic instability or severe infection,
- pregnant women,
- nursing mothers,
- persons deprived of their liberty by a judicial or administrative decision,
- patient being a measure of legal protection,
- patient requiring a transplant urgently
- patient younger than 18 years.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: patients
|
|
|
Other: control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Medical Research Council score (MRC score).
Time Frame: 12 months
|
The assessment of the strength for ICU patient
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
the length of stay in ICU,
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2013-A00760-45
- 2013-20 (Other Identifier: AP HM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Transplanted Patients
-
Gamida Cell ltdCompletedPatients Transplanted With NiCord/CordIn (Omidubicel)United States, Singapore, Spain, Netherlands
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingPediatric Liver Transplanted RecipientsUnited States
-
Fondazione IRCCS Policlinico San Matteo di PaviaCompletedCardiac Allograft Vasculopathy | Chronic Lung Allograft Dysfunction (CLAD) | Heart Transplanted Patients | Lung Transplanted PatientsItaly
-
University Hospital, MontpellierDepartment of Visceral and Digestive Surgery, Centre hospitalier de DunkerqueCompletedLeft Elective Colectomy | Renal Transplanted PatientsFrance
-
Cliniques universitaires Saint-Luc- Université...CompletedHealthy Donors | Pediatric Liver Transplanted Recipients
-
Rigshospitalet, DenmarkKarolinska Institutet; Oslo University Hospital; Helsinki University Central... and other collaboratorsUnknownComplication of Transplanted LiverDenmark, Finland, Norway, Sweden
-
Hospital Vall d'HebronCompletedInfection | Intestinal Microbiota | Complication of Transplanted Liver | Acute Rejection of Liver TransplantSpain
-
Talaris Therapeutics Inc.TerminatedTransplanted Organ RejectionUnited States
-
University of ZurichUniversity of Lausanne; University of Bern; University of Basel; Cantonal Hospital... and other collaboratorsRecruiting
-
Seoul National University HospitalActive, not recruitingRenal Transplanted Recipients | Kidney FunctionKorea, Republic of
Clinical Trials on experimental physical therapy
-
Foundation University IslamabadRecruitingCerebral Palsy (CP) | Functional MobilityPakistan
-
Cairo UniversityActive, not recruitingSubacromial Impingement SyndromeEgypt
-
Taibah UniversityRecruiting
-
Gabriela Lopes GamaCompletedCongenital Zika SyndromeBrazil
-
University of HailCompletedCerebral PalsySaudi Arabia
-
University of Sao Paulo General HospitalAgência Brasileira de Desenvolvimento Industrial (Brazilian Agency For Industrial...Not yet recruitingBrain Injuries | Spinal Cord Injuries | Muscle AtrophyBrazil
-
Riphah International UniversityCompletedSpastic Cerebral PalsyPakistan
-
Cairo UniversityCompletedChildren After Open Heart SurgeryEgypt
-
University of LahoreCompletedChronic StrokePakistan
-
Riphah International UniversityCompletedDevelopment DelayPakistan